Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy

Phase 4

Completed

• Conditions: Glaucoma

• Registration Number: NCT00444665
• Lead Sponsor: Alcon Research

Brief Summary

Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2007-03-07
• Study First Submitted QC: 2007-03-07
• Study First Posted: 2007-03-08
• Study Start: 2007-05
• Primary Completion: 2007-08
• Study Completion: 2007-08
• Status Verified: 2008-04
• Last Update Submitted: 2016-11-18
• Last Update Posted: 2016-11-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 750

Inclusion Criteria

• Adults with a clinical diagnosis of ocular hypertension, or primary open-angle, pigment dispersion or exfoliation glaucoma in at least one eye (study eye)

Exclusion Criteria

• Age

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Ocular Surface Disease Symptoms

Secondary Outcome Measures

Name	Time	Method
Intraocular pressure

Trial Locations

Locations (1)

Fridley; 🇺🇸 Fridley, Minnesota, United States